Conmed (CNMD) Accumulated Expenses (2010 - 2026)

Conmed's Accumulated Expenses history runs 17 years deep, the most recent figure standing at $60.9 million for Q1 2026.

• Quarterly Accumulated Expenses rose 5.52% year-over-year to $60.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $60.9 million (up 5.52% YoY) and the FY2025 annual result came in at $82.1 million, up 25.66% from the prior year.
• Accumulated Expenses was $60.9 million for Q1 2026 at Conmed, down from $82.1 million in the prior quarter.
• Across five years, Accumulated Expenses topped out at $82.1 million in Q4 2025 and bottomed at $45.4 million in Q1 2022.
• A 5-year average of $59.8 million and a median of $57.7 million in 2025 frame the typical range for Accumulated Expenses.
• Annual changes were most pronounced in 2022 — Accumulated Expenses dropped 9.51% — and 2023, when it grew 28.02%.
• Conmed's Accumulated Expenses stood at $54.7 million in 2022, then rose by 28.02% to $70.1 million in 2023, then retreated by 6.71% to $65.4 million in 2024, then gained by 25.66% to $82.1 million in 2025, then dropped by 25.87% to $60.9 million in 2026.
• Business Quant data shows CNMD's Accumulated Expenses at $60.9 million in Q1 2026, $82.1 million in Q4 2025, and $76.1 million in Q3 2025.